BioNTech SE (XBUL:22UA)
лв 110 0 (0%) Market Cap: 26.37 Bil Enterprise Value: -6.97 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 50/100

Full Year 2019 BioNTech SE Earnings Call Transcript

Mar 31, 2020 / 12:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the BioNTech fourth quarter and full year operational progress and financial results call. (Operator Instructions) I must advise you this call is being recorded today, Tuesday, the 31st of March, 2020.

And I would now like to hand the call over to the Vice President, Investor Relations and Business Strategy, Sylke Maas. Please go ahead.

Sylke Maas
BioNTech SE - VP of IR and Business Strategy

Thank you for joining us today for BioNTech's Fourth Quarter and Full Year 2019 Update Call. Before we start, we encourage you to view the slides for this webcast as well as the financial results press release issued this morning, both of which are accessible on our website in the Investors section. Slides 2 and 3 provides legal disclosures related to the pending acquisition of Neon Therapeutics.

As shown on Slide 4, during today's presentation, we will be making several forward-looking statements. These forward-looking statements include, but are not limited to, the timing for enrollment

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot